Treatment for Pheochromocytoma, Paraganglioma to Be Discontinued
Progenics Pharmaceuticals will stop producing Azedra (iobenguane I 131) injection due to a lack of commercial demand.
Source: cancertherapyadvisor.com
Stay updated with breaking news from Azedra Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Progenics Pharmaceuticals will stop producing Azedra (iobenguane I 131) injection due to a lack of commercial demand.